Oral management strategies for radiotherapy of head and neck cancer

被引:55
作者
Kawashita, Yumiko [1 ]
Soutome, Sakiko [1 ]
Umeda, Masahiro [2 ]
Saito, Toshiyuki [3 ]
机构
[1] Nagasaki Univ Hosp, Dept Oral Management Ctr, 1-7-1 Sakamoto, Nagasaki, Nagasaki 8528102, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki, Japan
[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Hlth, Nagasaki, Japan
关键词
Head and neck cancer; Radiotherapy; Oral management; CLINICAL-PRACTICE GUIDELINES; MODULATED RADIATION-THERAPY; DENTAL-CARIES; OSTEORADIONECROSIS; MUCOSITIS; PREVENTION; OSTEONECROSIS; JAW; CHEMORADIOTHERAPY; POSTIRRADIATION;
D O I
10.1016/j.jdsr.2020.02.001
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Radiotherapy, often with concomitant chemotherapy, has a significant role in the management of head and neck cancer, however, radiotherapy induces adverse events include oral mucositis, hyposalivation, loss of taste, dental caries, osteoradionecrosis, and trismus, all of which have an impact on patients' quality of life. Therefore, it is necessary to implement oral management strategies prior to the initiation of radiotherapy in patients with head and neck cancer. Since 2014, the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) have enumerated the "Principles of Dental Evaluation and Management (DENT-A)" in the section on head and neck cancers, however, oral management was not explained in detail. Oral management has not been achieved a consensus protocol. The aim of this literature is to show that oral management strategy include removal infected teeth before the start of radiotherapy to prevent osteoradionecrosis, oral care for preventing severe oral mucositis to support patient complete radiotherapy during radiotherapy, and prevent of dental caries followed by osteoradionecrosis after radiotherapy. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of The Japanese Association for Dental Science.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 70 条
  • [1] Ahadian Hakimeh, 2017, Asian Pac J Cancer Prev, V18, P721
  • [2] Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw
    Akashi M.
    Wanifuchi S.
    Iwata E.
    Takeda D.
    Kusumoto J.
    Furudoi S.
    Komori T.
    [J]. Oral and Maxillofacial Surgery, 2018, 22 (1) : 59 - 63
  • [3] Emerging evidence on the pathobiology of mucositis
    Al-Dasooqi, Noor
    Sonis, Stephen T.
    Bowen, Joanne M.
    Bateman, Emma
    Blijlevens, Nicole
    Gibson, Rachel J.
    Logan, Richard M.
    Nair, Raj G.
    Stringer, Andrea M.
    Yazbeck, Roger
    Elad, Sharon
    Lalla, Rajesh V.
    [J]. SUPPORTIVE CARE IN CANCER, 2013, 21 (11) : 3233 - 3241
  • [4] Early cellular alterations in bone after radiation therapy and its relation to osteoradionecrosis
    Al-Nawas, B
    Duschner, H
    Grötz, KA
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (08) : 1045 - 1045
  • [5] Oncologic outcomes of laparoscopic surgery for rectal cancer: A systematic review and meta-analysis of the literature
    Anderson, C.
    Uman, G.
    Pigazzi, A.
    [J]. EJSO, 2008, 34 (10): : 1135 - 1142
  • [6] Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
  • [7] [Anonymous], 1979, WHO HDB REP RES CANC
  • [8] [Anonymous], 2004, COCHRANE DB SYST REV
  • [9] Argiris A, 2003, CANC TREAT, V114, P15
  • [10] New foundations in understanding osteonecrosis of the jaws
    Assael, LA
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (02) : 125 - 126